Logo image of ALCJ.PA

CROSSJECT (ALCJ.PA) Stock Fundamental Analysis

EPA:ALCJ - Euronext Paris - Matif - FR0011716265 - Common Stock - Currency: EUR

1  +0 (+0.1%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALCJ. ALCJ was compared to 54 industry peers in the Health Care Equipment & Supplies industry. ALCJ may be in some trouble as it scores bad on both profitability and health. ALCJ has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCJ has reported negative net income.
In the past year ALCJ has reported a negative cash flow from operations.
In the past 5 years ALCJ always reported negative net income.
ALCJ had a negative operating cash flow in each of the past 5 years.
ALCJ.PA Yearly Net Income VS EBIT VS OCF VS FCFALCJ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

ALCJ's Return On Assets of -31.63% is on the low side compared to the rest of the industry. ALCJ is outperformed by 79.63% of its industry peers.
The Return On Equity of ALCJ (-593.99%) is worse than 83.33% of its industry peers.
Industry RankSector Rank
ROA -31.63%
ROE -593.99%
ROIC N/A
ROA(3y)-32.8%
ROA(5y)-31.4%
ROE(3y)-377.91%
ROE(5y)-284%
ROIC(3y)N/A
ROIC(5y)N/A
ALCJ.PA Yearly ROA, ROE, ROICALCJ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400 -500

1.3 Margins

ALCJ has a better Gross Margin (993.79%) than 100.00% of its industry peers.
ALCJ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 993.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCJ.PA Yearly Profit, Operating, Gross MarginsALCJ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

ALCJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCJ has more shares outstanding
The number of shares outstanding for ALCJ has been increased compared to 5 years ago.
ALCJ has a worse debt/assets ratio than last year.
ALCJ.PA Yearly Shares OutstandingALCJ.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ALCJ.PA Yearly Total Debt VS Total AssetsALCJ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ALCJ has an Altman-Z score of -0.48. This is a bad value and indicates that ALCJ is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALCJ (-0.48) is worse than 70.37% of its industry peers.
ALCJ has a Debt/Equity ratio of 11.67. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 11.67, ALCJ is not doing good in the industry: 85.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 11.67
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACCN/A
WACC6.92%
ALCJ.PA Yearly LT Debt VS Equity VS FCFALCJ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALCJ has a Current Ratio of 1.58. This is a normal value and indicates that ALCJ is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALCJ (1.58) is comparable to the rest of the industry.
A Quick Ratio of 0.89 indicates that ALCJ may have some problems paying its short term obligations.
ALCJ has a Quick ratio (0.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.89
ALCJ.PA Yearly Current Assets VS Current LiabilitesALCJ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALCJ shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.92%.
Looking at the last year, ALCJ shows a very negative growth in Revenue. The Revenue has decreased by -71.00% in the last year.
EPS 1Y (TTM)-1.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.25%
Revenue 1Y (TTM)-71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ALCJ will show a very strong growth in Earnings Per Share. The EPS will grow by 39.59% on average per year.
ALCJ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 68.53% yearly.
EPS Next Y26.77%
EPS Next 2Y57.1%
EPS Next 3Y53.15%
EPS Next 5Y39.59%
Revenue Next Year3.06%
Revenue Next 2Y105.3%
Revenue Next 3Y81.25%
Revenue Next 5Y68.53%

3.3 Evolution

ALCJ.PA Yearly Revenue VS EstimatesALCJ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALCJ.PA Yearly EPS VS EstimatesALCJ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALCJ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 5.93, the valuation of ALCJ can be described as very cheap.
96.30% of the companies in the same industry are more expensive than ALCJ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.86, ALCJ is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.93
ALCJ.PA Price Earnings VS Forward Price EarningsALCJ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCJ.PA Per share dataALCJ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALCJ's earnings are expected to grow with 53.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.1%
EPS Next 3Y53.15%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROSSJECT

EPA:ALCJ (5/2/2025, 7:00:00 PM)

1

+0 (+0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)09-22 2025-09-22
Inst Owners0.4%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap46.23M
Analysts84.44
Price Target3.93 (293%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.94%
PT rev (3m)-4.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.61%
EPS NY rev (3m)-12.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.93
P/S 318.83
P/FCF N/A
P/OCF N/A
P/B 26.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)0.17
Fwd EY16.86%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0
BVpS0.04
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.63%
ROE -593.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 993.79%
FCFM N/A
ROA(3y)-32.8%
ROA(5y)-31.4%
ROE(3y)-377.91%
ROE(5y)-284%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 11.67
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 168.89%
Cap/Sales 3028.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.89
Altman-Z -0.48
F-Score3
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)152.85%
Cap/Depr(5y)140.85%
Cap/Sales(3y)1954.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.25%
EPS Next Y26.77%
EPS Next 2Y57.1%
EPS Next 3Y53.15%
EPS Next 5Y39.59%
Revenue 1Y (TTM)-71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.06%
Revenue Next 2Y105.3%
Revenue Next 3Y81.25%
Revenue Next 5Y68.53%
EBIT growth 1Y6.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.64%
EBIT Next 3Y59.57%
EBIT Next 5Y44.67%
FCF growth 1Y-6.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.91%
OCF growth 3YN/A
OCF growth 5YN/A